What it tells the body to do
Sermorelin is a lab-made version of the first part of growth hormone-releasing hormone. It tells the pituitary, a small gland below the brain, to release growth hormone. It isn’t growth hormone itself.
In a study of children with growth hormone deficiency, growth sped up during the first year of treatment. The children had a diagnosed hormone shortage. The study had no comparison group, so it couldn’t tell us how sermorelin measured up against another treatment.
A short study in older men found higher growth hormone and IGF-1, a related growth factor. That’s a hormone finding. It doesn’t establish better sleep or lasting health benefits, however tempting it is to read those into it.
The old approval had specific uses
Sermorelin acetate was once approved in the U.S. as Geref. One use tested whether the pituitary could release growth hormone. The other treated children with idiopathic growth hormone deficiency, a shortage without a known cause, and growth failure.
Geref was discontinued in 2008. Its approvals were withdrawn in 2009. The FDA later determined that it hadn’t left the market for safety or effectiveness reasons.
That last finding matters, but it doesn’t approve today’s compounded preparations. There’s no current FDA-approved sermorelin product on sale in the U.S. Adult wellness use isn’t the old childhood approval carried forward.
Sleep stories leave questions open
People in peptide-use communities describe better sleep and energy. Those are anecdotes, not clinical proof. They don’t tell us how often a benefit happens or what else might explain it.
The clinical review of older studies reports temporary facial flushing and pain at injection sites. Those observations, mostly from childhood treatment, don’t settle the safety of adult compounded use. Long-term adult wellness benefits remain unproven.
The prescription decision
Promise Peptides offers prescription sermorelin at mypromise.com. Care is limited to the United States, where a licensed U.S. provider reviews your situation and decides whether to prescribe; not everyone qualifies. Its compounded medicines are not FDA-approved.
More generally, FDA approval doesn’t cover compounded medicines. A prescription decision is about an individual’s care. It doesn’t establish that a preparation passed FDA review, or tell us what’s available in Australia. Our comparison keeps each substance’s evidence and access questions together.